FROM Carolyn Y. Johnson
An old drug gets a ridiculously high price….again Are incentives for so-called "orphan drugs" being misused to jack up the price of one medication by 4000 percent? Photo by Chris Potter A rare form of muscular dystrophy has long been treated in the US by a steroid imported from overseas at a price of $1200 a year. Now the FDA has approved its manufacture and distribution in this country by the drug company Marathon. The new price is $89,000 a year — reduced to $54,000 after rebates and discounts. We get perspective from Carolyn Johnson, who covers the business of medicine for the Washington Post , and Dr. Aaron Kesselheim, a professor of medicine at Harvard, where he's also Director of the program on Regulation, Therapeutics and Law.
Do Hungry Monkeys Live Longer? For 70 years, it's been known that the lives of yeast, flies and laboratory rats can be extended by dramatically cutting the number of calories in their diets. Now, after two decades of research, scientists in Wisconsin have done the same with rhesus monkeys, animals which are much more like human beings. We hear more from Carolyn Johnson of the Boston Globe .
Concern deepens amid Trump's controversies President Trump delivered today's commencement speech to the Coast Guard Academy in Connecticut. As he praised the accomplishments of the graduates, he listed some of his own… and made reference to reports that he leaked intelligence to the Russians and tried to shut down an FBI Investigation into his associates.
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.